A coffee with your doughnut could protect against Alzheimer's disease

The BBB protects the central nervous system from the rest of the body's circulation, providing the brain with its own regulated microenvironment. Previous studies have shown that high levels of cholesterol break down the BBB which can then no longer protect the central nervous system from the damage caused by blood borne contamination. BBB leakage occurs in a variety of neurological disorders such as Alzheimer's disease.

In this study, researchers from the University of North Dakota School of Medicine and Health Sciences gave rabbits 3 mg caffeine each day – the equivalent of a daily cup of coffee for an average-sized person. The rabbits were fed a cholesterol-enriched diet during this time.

After 12 weeks a number of laboratory tests showed that the BBB was significantly more intact in rabbits receiving a daily dose of caffeine.

“Caffeine appears to block several of the disruptive effects of cholesterol that make the blood-brain barrier leaky,” says Jonathan Geiger, University of North Dakota School of Medicine and Health Sciences. “High levels of cholesterol are a risk factor for Alzheimer's disease, perhaps by compromising the protective nature of the blood-brain barrier. For the first time we have shown that chronic ingestion of caffeine protects the BBB from cholesterol-induced leakage.”

Caffeine appears to protect BBB breakdown by maintaining the expression levels of tight junction proteins. These proteins bind the cells of the BBB tightly to each other to stop unwanted molecules crossing into the central nervous system.

The findings confirm and extend results from other studies showing that caffeine intake protects against memory loss in aging and in Alzheimer’s disease.

“Caffeine is a safe and readily available drug and its ability to stabilise the blood-brain barrier means it could have an important part to play in therapies against neurological disorders,” says Geiger.

Source: BioMed Central

The blood-brain barrier: A misunderstood key to finding life-saving cures to brain disease
An international team of scientists that includes a Saint Louis University researcher suggest several strategies to propel research for treatments of brain diseases that include multiple sclerosis, Alzheimer’s disease, obesity and stroke in the January issue of the Lancet Neurology.
Brain study may lead to improved epilepsy treatments
Using a rodent model of epilepsy, researchers found one of the body’s own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain. Researchers say this may explain why approximately 30 percent of patients with epilepsy do not respond to antiepileptic medications.
'Tis the season to be careful URI expert offers tips for shopping safely online
Santa Claus is computer literate and Rudolph is unemployed since more and more people are clicking off their holiday lists online and getting them delivered overnight, often by people with brown uniforms instead of by reindeer with red noses.
Globe Talk: U.S., Europe still under pressure
The telecommunications industry continued to be cutthroat in 2005 worldwide, not least with SBC Communications buying out AT&T and Verizon expected to merge with MCI by early next year.
Briefs: Telecoms outsourcing back-office work
Standard & Poor's said Monday telecom companies are outsourcing more of their back-office functions such as billing and developing customer-care technology.
Nanoparticles Illuminate Brain Tumors for Days Under MRI
OHSU study finds tiny crystals also help brain lesion tissue to be viewed under microscope

PORTLAND, Ore. - A research team from Oregon Health and Science University and the Portland Veterans Affairs Medical Center is demonstrating some of the world's first clinical applications for nanometer-size particles in the brain.

A coffee with your doughnut could protect against Alzheimer's disease

Related stories:

News discussion: